Search research articles
Contact Us
Filters
Showing results (111-120 of 151) with videos related to
Page
of 16
Sort By:
Medicina Clinica
|
October 7, 1995
[High-dosage chemotherapy and the autologous transplantation of peripheral hematopoietic progenitor cells in breast cancer: the initial results, analysis of toxicity and the necessary support means]
C Sola Rocabert, R Mesía, L Mendoza, et al.
Oncogene
|
August 15, 2012
Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network
M Castelli, S Pieroni, C Brunacci, et al.
Cells
|
July 2, 2021
Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting
Matteo Puccetti, Marilena Pariano, Giorgia Renga, et al.
Oncology
|
August 28, 2004
Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapy
M Martin-Richard, M Muñoz, J Albanell, et al.
Revue Des Maladies Respiratoires
|
July 17, 2007
[Cystic fibrosis: how to use pulmonary function tests]
F P Counil, C Karila, M Le Bourgeois, et al.
Expert Opinion on Biological Therapy
|
August 1, 2018
Cellular proteostasis: a new twist in the action of thymosin α1
Claudia Stincardini, Giorgia Renga, Valeria Villella, et al.
Frontiers in Immunology
|
November 5, 2019
Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk
Monica Borghi, Marilena Pariano, Valentina Solito, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
April 17, 2007
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients
Zh Mihaylova, V Ludovini, V Gregorg, et al.
Life Science Alliance
|
August 21, 2020
Thymosin α1 protects from CTLA-4 intestinal immunopathology
Giorgia Renga, Marina M Bellet, Marilena Pariano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients
J Baselga, A Llombart-Cussac, M Bellet, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 151) with videos related to
Sort By:
Page
of 16
Medicina Clinica
|
October 7, 1995
[High-dosage chemotherapy and the autologous transplantation of peripheral hematopoietic progenitor cells in breast cancer: the initial results, analysis of toxicity and the necessary support means]
C Sola Rocabert, R Mesía, L Mendoza, et al.
Oncogene
|
August 15, 2012
Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19 Arf network
M Castelli, S Pieroni, C Brunacci, et al.
Cells
|
July 2, 2021
Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting
Matteo Puccetti, Marilena Pariano, Giorgia Renga, et al.
Oncology
|
August 28, 2004
Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapy
M Martin-Richard, M Muñoz, J Albanell, et al.
Revue Des Maladies Respiratoires
|
July 17, 2007
[Cystic fibrosis: how to use pulmonary function tests]
F P Counil, C Karila, M Le Bourgeois, et al.
Expert Opinion on Biological Therapy
|
August 1, 2018
Cellular proteostasis: a new twist in the action of thymosin α1
Claudia Stincardini, Giorgia Renga, Valeria Villella, et al.
Frontiers in Immunology
|
November 5, 2019
Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk
Monica Borghi, Marilena Pariano, Valentina Solito, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
April 17, 2007
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients
Zh Mihaylova, V Ludovini, V Gregorg, et al.
Life Science Alliance
|
August 21, 2020
Thymosin α1 protects from CTLA-4 intestinal immunopathology
Giorgia Renga, Marina M Bellet, Marilena Pariano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients
J Baselga, A Llombart-Cussac, M Bellet, et al.
Page
of 16